All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
- This event has passed.
ARUK Lab Notes – Emerging treatments
25/04/2023 @ 4:00 pm - 5:00 pm
Alzheimer’s Research UK Lab Notes. Find out about the research taking place at the UK’s specially-created Drug Discovery Alliance, which brings together world-leading dementia scientists from the Universities of Oxford, Cambridge and University College London.
Each institution houses dedicated biology and chemistry teams to evaluate promising new drug targets. Together, the Drug Discovery Institutes are exploring a wide range of disease mechanisms spanning the full spectrum of dementias.
Fiona and Paul will talk to us about the Drug Discovery Institutions, and share some of the exciting projects taking place.
The event will take place online via Zoom, and it is free to attend. It is open to everyone, and no previous knowledge of dementia or research is required.
Register to Attend
- Professor Paul Brennan is the Chief Scientific Officer of the Oxford Drug Discovery Institute (ODDI) at the University of Oxford. He joined the ODDI as the Head of Chemistry in 2015. As a highly accomplished medicinal chemist with particular expertise in early drug discovery, he has been instrumental in developing and leading the Institute’s diverse portfolio of drug discovery projects.
- Professor Fiona Ducotterd is Chief Scientific Officer at the Alzheimer’s Research UK Drug Discovery Institute at UCL in London where she leads a team of multidisciplinary scientists discovering new medicines for neurodegenerative diseases including Alzheimer’s diseaseFiona is also a mentor and coach to early career scientists and other professionals, particularly those that are under-represented in the industry and a mum to 1 year old Isla and fur baby, Yuna.
